TNF Pharmaceuticals (TNFA) announced that its board of directors has authorized a reverse stock split of the company’s common stock at a ratio of one post-split share for every 100 pre-split shares. The company’s common stock will begin trading on a split-adjusted basis upon market open on Tuesday, September 2. The company expects to provide operational business updates coinciding with the completion of the reverse stock split.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNFA: